Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Research article

Methamphetamine use is associated with high levels of depressive symptoms in adolescents and young adults in Rural Chiang Mai Province, Thailand

Authors: Lauren E. DiMiceli, Susan G. Sherman, Apinun Aramrattana, Bangorn Sirirojn, David D. Celentano

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

High levels of depressive symptoms often occur among individuals that use or that are dependent on methamphetamine (MA). Thailand is currently experiencing an epidemic of MA use among youth. Understanding the nature of the relationship between depressive symptoms and MA use and identifying those most at risk can further understanding of prevention and treatment options for youth who use MA and present with depressive symptoms.

Methods

In 2011, we conducted a cross sectional epidemiologic study that examined associations between MA use and high levels of depressive symptoms among adolescents and young adults aged 14–29 living in Chiang Mai province, Thailand. A combination of cluster and systematic sampling was conducted to obtain a study sample of participants actively recruited in Chiang Mai province. Depressive symptoms were measured using a Thai translation of the Centers for Epidemiologic Studies Depression scale (CES-D). The independent variables measured reported lifetime and recent MA use within the past 3 months. Multivariate logistic regression models were used to assess associations between MA use and high levels of depressive symptoms.

Results

Approximately 19 % (n = 394) of the sample reported ever having consumed MA and 31 % (n = 124) of lifetime users reported recent MA use within the past 3 months. Recent MA use was associated with high levels of depressive symptoms (aPOR recent use: 2.60, 95 % CI: 1.20, 5.63).

Conclusions

This is one of the first studies to examine the association between MA use and high levels of depressive symptoms in a general Thai population. The odds of having high levels of depressive symptoms was significantly greater among recent MA users compared to non-users. These findings support the need for policies, programs and interventions to prevent and treat depressive symptoms presenting among MA using Thai adolescents and young adults in rural Chiang Mai province, Thailand to aid in cessation of MA use. Furthermore, additional research is needed to investigate treatment options for adolescents and young adults in Thailand that use MA and present with high levels of depressive symptoms.
Literature
1.
Razak MH, Jittiwutikarn J, Suriyanon V, et al. HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J Acquir Immune Defic Syndr. 2003;33(2):259–66.CrossRefPubMed
2.
Melbye K, Khamboonruang C, Kunawararak P, et al. Lifetime correlates associated with amphetamine use among northern Thai men attending STD and HIV anonymous test sites. Drug Alcohol Depend. 2002;68(3):245–53.CrossRefPubMed
3.
Sherman SG, German D, Sirirojorn B, et al. Initiation of methamphetamine use among young Thai drug users: a qualitative study. J Adolesc Health. 2008;42(1):36–42.CrossRefPubMed
4.
Cohen A. Crazy for Ya Ba: methamphetamine use among Northern Thai Youth. Int J Drug Policy. 2015;25(4):776–82.CrossRef
5.
Chomchai C, Chomchai S. Global patterns of methamphetamine use. Curr Opin Psychiatry. 2015;28(4):269–74.CrossRefPubMed
6.
Farrell M, Marsden J. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction. 2002;97(7):771–2.CrossRefPubMed
7.
Chin KL. The golden triangle. Inside Southeast Asia’s Drug Trade. Ithica: Cornell University Press; 2009.
8.
Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253–62.CrossRefPubMed
9.
Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13(2):181–90.CrossRefPubMed
10.
Kalechstein AD, Newton TF, Longshore D, Anglin MD, van Gorp WG, Gawin FH. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci. 2000;12(4):480–4.CrossRefPubMed
11.
McKetin R, Lubman DI, Lee NM, Ross JE, Slade TN. Major depression among methamphetamine users entering drug treatment programs. Med J Aust. 2011;195(3):S51–5.PubMed
12.
Sutcliffe CG, German D, Sirirojorn B, Latkin C, Aramrattana A, Sherman SG, et al. Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug Alcohol Depend. 2009;101(3):146–51.CrossRefPubMedPubMedCentral
13.
Siriwanarangsan P, Liknapichitkul D, Khandelwal SK. Thailand mental health country profile. Int Rev Psychiatry. 2004;16(1–2):150–8.CrossRefPubMed
14.
Latimore AD, Aramrattana A, Sherman SG, et al. Sexually transmitted infection risk behaviors in rural Thai adolescents and young adults: support for sex- and age-specific interventions. Sex Transm Dis. 2013;40(3):216–20.CrossRefPubMedPubMedCentral
15.
Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
16.
Trangkasombat U, Larpboonsarp V, Havanond P. CES-D as a screen for depression in adolescents. J Psychiatry Assoc Thail. 1997;42:2–13.
17.
Charoensuk S. Factors influencing depression in Thai adolescents, ProQuest Dissertations and Theses. 2005.
18.
Needle R, Fisher D, Weatherby N, et al. Reliability of self reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9:242–50.CrossRef
19.
Saunders JB, Aasland OG, Babor TF, de Jr lF, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction. 1993;88:791–804.CrossRefPubMed
20.
Suttajit S, Kittirattanapaiboon P, Junsirimongkol B, Likhitsathian S, Srisurapanont M. Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: findings from the 2008 Thai National Mental Health survey. Addict Behav. 2012;37(12):1395–9.CrossRefPubMed
21.
Beck A, Alford BA. Depression: causes and treatment. 2nd ed. Philadelphia: University of Pennsylvania Press; 2009.
22.
Vittinghoff DV, Glidden DV, Shiboski SC, McCulloch CE. In: Gail M KK, Samet J, Tsiatis A, Wong W, editors. Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. New York: Springer Science and Business Media, LLC; 2005.
23.
Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48(1):43–51.CrossRefPubMed
24.
Markou A, Kenny PJ. Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotox Res. 2002;4(4):297–313.CrossRefPubMed
25.
Kim D. Blues from the neighborhood? Neighborhood characteristics and depression. Epidemiol Rev. 2008;30:101–17.CrossRefPubMed
26.
Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998;18(3):135–74.CrossRefPubMed
27.
Shoptaw S, Huber A, Peck J. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2006;85(1):12–8.CrossRefPubMed
28.
Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend. 2001;63(3):207–14.CrossRefPubMed
29.
McDowell D, Nunes EV, Seracini AM, et al. Desipramine treatment of cocaine dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend. 2005;80(2):209–21.CrossRefPubMed
30.
Elkashef AM, Rawson RA, Anderson AL, et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology. 2008;33(5):162–70.CrossRef
31.
Hellem TL, Lundberg KJ, Renshaw PF. A review of treatment options for co- occuring methamphetamine use disorders and depression. J Addict Nurs. 2015;26(1):14–23.CrossRefPubMedPubMedCentral
32.
van Griensven F, Supawitkul S, Kilmarx PH. Rapid assessment of sexual behavior, drug use, human immunodeficiency virus, and sexually transmitted diseases in northern Thai youth using audio-computer-assisted self-interviewing and noninvasive specimen collection. Pediatrics. 2001;108(1):E13.CrossRefPubMed
Metadata
Title
Methamphetamine use is associated with high levels of depressive symptoms in adolescents and young adults in Rural Chiang Mai Province, Thailand
Authors
Lauren E. DiMiceli
Susan G. Sherman
Apinun Aramrattana
Bangorn Sirirojn
David D. Celentano
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-2851-1

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue

Research article

Associations between non-discrimination and training policies and physicians’ attitudes and knowledge about sexual and gender minority patients: a comparison of physicians from two hospitals

Research article

Estimating micro area behavioural risk factor prevalence from large population-based surveys: a full Bayesian approach

Research article

Factors associated with secondhand smoke exposure in different settings: Results from the German Health Update (GEDA) 2012

Research article

Too much sitting and all-cause mortality: is there a causal link?

Research article

Do socio-cultural factors influence medical students’ health status and health-promoting behaviors? A cross-sectional multicenter study in Germany and Hungary

Research article

Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada